Oracle Corporation (ORCL) reached an all-time high of $345.72 in September 2025, fueled by optimism around its role as a key AI infrastructure provider. Since then, the stock has fallen more than half its value amid worries over heavy capital spending, rising debt, and negative free cash flow. With shares now near $130 — down approximately 48% over the past twelve months — the possibility of a return to $300 stands out as one of the more closely watched questions in tech investing. The stock traded above $300 as recently as mid-2025, so this level serves as both a psychological and technical reference point.
Oracle's fiscal 2026 revenue reached $67.4 billion, up 17% year-over-year, while net income rose 37% to approximately $17 billion. The company trades at a price-to-earnings (P/E) ratio of roughly 22, well below its own five-year median P/E of about 32 and the broader technology sector average near 34. This valuation reflects investor caution around Oracle's capital structure more than doubts about revenue growth. The company ended fiscal 2026 with $638 billion in RPO — a 363% increase from the prior year — which offers strong visibility into future revenue. Approximately $77 billion of that backlog is expected to convert into recognized revenue during fiscal 2027 alone. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The case for Oracle reaching $300 centers on its fast-growing cloud infrastructure business. OCI revenue surged 84% to 93% year-over-year in recent quarters, supported by strong demand for AI training compute. Oracle's role in Project Stargate — the $500 billion AI infrastructure initiative alongside SoftBank, NVDA, and OpenAI — places it at the center of one of the largest technology buildouts in history. Oracle has also signed major cloud contracts with META and other large customers. Management guided for fiscal 2027 revenue of approximately $90 billion, a 34% increase, and analysts project fiscal 2028 revenue could reach $130 billion as OCI capacity comes online. Combined with expectations that infrastructure margins will improve once data centers reach full utilization, Oracle's EPS could surpass $10 by fiscal 2028. At a 30x P/E multiple — in line with Oracle's three-year historical average — that would support a stock price above $300.
The challenges are significant and explain much of the current valuation. Oracle's debt load rose from approximately $85 billion to roughly $167 billion over the past year to fund data center construction. Free cash flow turned deeply negative at negative $23.7 billion in fiscal 2026. S&P downgraded Oracle's credit rating to BBB-, and credit default swap spreads widened. The company plans to raise an additional $40 billion through debt and equity in fiscal 2027, including a $20 billion share sale that will dilute existing shareholders. Oracle also cut approximately 21,000 jobs — about 13% of its workforce — during fiscal 2026 as part of an AI-driven restructuring. Gross margins are expected to face near-term pressure as new data centers ramp up before reaching full utilization. If AI infrastructure demand slows or hyperscale customers reduce GPU prepayments, the RPO conversion story could weaken.
Wall Street remains cautiously optimistic overall. Of approximately 44 analysts covering Oracle, the majority rate the stock a Buy or Strong Buy, with an average 12-month price target near $248 to $261 — implying roughly 90% to 100% upside from current levels. The range is wide: the most cautious targets sit around $155 to $160, while Guggenheim maintains a high target of $400. TD Cowen, KeyBanc, and several other firms hold at $300. However, multiple firms — including Baird, Piper Sandler, and BMO Capital — have lowered their targets during 2026 amid concerns about financing needs and the timeline for margin recovery.
From a technical standpoint, Oracle trades well below all major moving averages, approximately 21% beneath its 50-day moving average and roughly 28% under its 200-day moving average. The 52-week low of $114.50 represents important support — a break below that level would indicate further weakness. On the upside, the $200 level marks the first significant resistance zone, aligning with several revised analyst targets. Beyond $200, the $250 zone — near consensus — forms the next hurdle, with $300 serving as both a psychological round number and the key recovery target. The stock's beta of 1.71 highlights its sensitivity to shifts in market sentiment around AI spending.
The question of whether Oracle can reach $300 again is not about demand — the $638 billion RPO backlog confirms that clearly. The real issues are whether Oracle can finance its infrastructure buildout without damaging its balance sheet and convert booked contracts into recognized revenue and free cash flow before credit markets grow impatient. The path to $300 likely requires sustained OCI growth above 80% through at least fiscal 2027 and visible margin improvement as data centers reach full utilization. Neither is guaranteed, but both are supported by contract data and management guidance. Investors should monitor quarterly OCI revenue growth rates, RPO conversion trends, gross margin trajectory, and any changes to Oracle's financing plans. A return to $300 probably extends into late 2027 or 2028, depending on execution that bridges the gap between the company's demand pipeline and its capital requirements.
To navigate volatile situations like this one, I often turn to Tickeron’s AI Daily Buy/Sell Signals. The tool uses artificial intelligence to monitor thousands of stocks and generate Buy, Sell, or Hold signals based on technical patterns and market conditions, helping separate real trend shifts from short-term noise when following a multi-year recovery story like Oracle’s.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
ORCL moved above its 50-day moving average on August 21, 2026 date and that indicates a change from a downward trend to an upward trend. In of 32 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ORCL's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where ORCL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ORCL just turned positive on July 22, 2026. Looking at past instances where ORCL's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .
The 10-day moving average for ORCL crossed bullishly above the 50-day moving average on August 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ORCL advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on August 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ORCL as a result. In of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORCL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ORCL broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ORCL entered a downward trend on August 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.236) is normal, around the industry mean (22.706). P/E Ratio (25.123) is within average values for comparable stocks, (70.701). Projected Growth (PEG Ratio) (0.828) is also within normal values, averaging (2.165). Dividend Yield (0.014) settles around the average of (0.021) among similar stocks. P/S Ratio (6.337) is also within normal values, averaging (111.934).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ORCL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of a diversified line of business software products
Industry ComputerCommunications